Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Fahadullah Khan"'
Publikováno v:
Food Weekly News; 10/17/2024, p34-34, 1p
Publikováno v:
The Clinical Respiratory Journal, Vol 15, Iss 1, Pp 97-108 (2021)
Abstract Background Hospitalized patients with tuberculosis (TB) are prescribed with drugs having high risk of potential drug‐drug interactions (pDDIs) and adverse drug effects (ADEs). Objectives To explore the adverse effects of anti‐tuberculosi
Externí odkaz:
https://doaj.org/article/5bffac5fff82422f98a7aa4822d8e416
Publikováno v:
BMC Psychiatry, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background QT interval prolongation is a growing concern worldwide, posing psychiatric patients to life-threatening fatal arrhythmias i.e., torsade de pointes. This study aimed to identify the prevalence of QT interval prolongation, its asso
Externí odkaz:
https://doaj.org/article/e4881f5d802943cebb6c8919a09a8536
Autor:
Mohammad Ismail, Sehrash Khan, Fahadullah Khan, Sidra Noor, Hira Sajid, Shazia Yar, Irum Rasheed
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
Abstract Background Cancer patients often receive multiple drugs to maximize their therapeutic benefit, treat co-morbidities and counter the adverse effects of chemotherapy. Concomitant administration of multiple drugs increases the risk of drug inte
Externí odkaz:
https://doaj.org/article/34db49eb96eb4841a7c4e34be947433a
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 56 (2020)
Hospitalized patients with left ventricular failure (LVF) are at high risk for potential drug-drug interactions (pDDIs) and its related adverse effects owing to multiple risk factors such as old age, comorbidities and polypharmacy. This cross-section
Externí odkaz:
https://doaj.org/article/a9816aac4be14948bec3510e43f21ecc
Publikováno v:
Frontiers in Pharmacology, Vol 10 (2019)
Introduction: Hospitalized patients with urinary tract infections (UTIs) often present with comorbid illnesses and are subsequently prescribed multiple medications, which increases the likelihood of drug-drug interactions. Therefore, this study aimed
Externí odkaz:
https://doaj.org/article/d8dee4b5db7041c5a10e5990f1d08c0d
Publikováno v:
Expert Opinion on Drug Safety. 20:101-108
Background: This study aimed to measure the association of various H1-antihistamines (H1A) with Torsade de Pointes (TdP), and present a comprehensive overview of H1A-induced TdP cases reported to the Food and Drug Administration Adverse Event Reporti
Publikováno v:
The Clinical Respiratory Journal. 15:97-108
BACKGROUND Hospitalized patients with tuberculosis (TB) are prescribed with drugs having high risk of potential drug-drug interactions (pDDIs) and adverse drug effects (ADEs). OBJECTIVES To explore the adverse effects of anti-tuberculosis (anti-TB) d
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Volume: 56, Article number: e18326, Published: 06 NOV 2020
Brazilian Journal of Pharmaceutical Sciences, Vol 56 (2020)
Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e18326
Brazilian Journal of Pharmaceutical Sciences; v. 56 (2020); e18326
Brazilian Journal of Pharmaceutical Sciences
Universidade de São Paulo (USP)
instacron:USP
Brazilian Journal of Pharmaceutical Sciences, Vol 56 (2020)
Brazilian Journal of Pharmaceutical Sciences; Vol. 56 (2020); e18326
Brazilian Journal of Pharmaceutical Sciences; v. 56 (2020); e18326
Brazilian Journal of Pharmaceutical Sciences
Universidade de São Paulo (USP)
instacron:USP
Hospitalized patients with left ventricular failure (LVF) are at high risk for potential drug-drug interactions (pDDIs) and its related adverse effects owing to multiple risk factors such as old age, comorbidities and polypharmacy. This cross-section
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b166da94f68851830cb90cd02b9e0ff
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502020000100589&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502020000100589&lng=en&tlng=en
Autor:
Sehrash Khan, Hira Sajid, Fahadullah Khan, Sidra Noor, Shazia Yar, Irum Rasheed, Mohammad Ismail
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-9 (2020)
BMC Cancer
BMC Cancer
Background Cancer patients often receive multiple drugs to maximize their therapeutic benefit, treat co-morbidities and counter the adverse effects of chemotherapy. Concomitant administration of multiple drugs increases the risk of drug interactions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53e1f31e11d6734aba790cb975fdeaf9
https://doi.org/10.21203/rs.2.22832/v1
https://doi.org/10.21203/rs.2.22832/v1